Kaltura, Inc. (NASDAQ:KLTR) submitted its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing its filing status, share count, and company classifications, with the financial statements and management discussion sections referenced in the table of contents but not fully reproduced …
Independent Bank Corp. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the fiscal quarter ended September 30, 2026, disclosing consolidated financial results including total assets of $25.01 billion and net interest income of $220.7 million for the …
Groupon, Inc. filed a Form 8-K on November 9, 2026, announcing the release of its financial results for the fiscal quarter ended September 30, 2026, via an attached earnings press release.
Uniti Group Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the fiscal period ended September 30, 2026, and reporting 242,826,817 shares of common stock outstanding as of November 2, 2026.
Life360, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing condensed consolidated balance sheet figures and a share count of 81,755,320 as of November 3, 2026.
Immunome, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net loss of $212.749 million for the nine months ended September 30, 2026.
Insight Digital Partners II filed a Form 10-Q with the SEC on November 9, 2026, reporting financial results for the quarter and nine months ended September 30, 2026.
Ceva, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting financial results for the three and nine months ended on that date.
ZipRecruiter, Inc. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the fiscal quarter ended September 30, 2026, disclosing share counts as of November 2, 2026, and providing financial statements, management discussion, and an updated risk factor section.
Zentalis Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results, operational updates, and risk factors for the quarter.